Guy de Martynoff

Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France.

Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France.

Remora Partners SA operates as an investment advisor. The private company is based in Lausanne, CH. and has subsidiaries in Switzerland and United States.

Remora Partners SA operates as an investment advisor. The private company is based in Lausanne, CH. and has subsidiaries in Switzerland and United States.